Overview

Smoking Relapse Prevention in Schizophrenia

Status:
Completed

Trial end date:
2009-08-01

Target enrollment:

Participant gender:

Summary

This study seeks to determine if continued treatment with bupropion and nicotine replacement therapy (NRT) can reduce the smoking relapse rate in patients with schizophrenia.

Phase:

Phase 4

Details

Lead Sponsor:

North Suffolk Mental Health Association

Treatments:

Bupropion
Nicotine